Health Condition 1: null- Atrial fibrillation, DVT (Deep Vein Thrombosis) and Heart Valve Replaced Patients who are on treatment with oral anticoagulants
Conditions
Interventions
Intervention1: Intervention group (Pharmacist Providing pharmaceutical care services through Patient education on safe use of Oral anticoagulants): Intervention group (Pharmacist Providing pharmaceuti
Sponsors
Kiran Majjigeri
Eligibility
Inclusion criteria
Inclusion criteria: Patients age from 18 years to 80 years of either sex diagnosed with atrial fibrillation, patients undergone valve replacement therapy, patients with DVT or having risk of DVT and should be newly started with Vit-K oral anticoagulants for minimum of three months treatment plan. Patients should know to read English or any of the local languages Kannada, Marathi and Hindi.
Exclusion criteria
Exclusion criteria: Patients with severe renal insufficiency, who are on dialysis, patients with active liver disease, pregnant patients, bleeding disorders, patients having visual and hearing impairment, Patients suffering from lupus anticoagulant or antiphospholipid syndrome.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patients experiencing bleeding /or thromboembolic events. Incidence of fatal bleeding, major bleeding, minor bleeding, and thromboembolic events and death.Timepoint: 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Time in Therapeutic Range (TTR), subtherapeutic range, or supratherapeutic range. Patientâ??s knowledge on OACs (oral anticoagulants) therapy. Cessation of OACs therapy or unplanned hospital readmission for any other cause.Timepoint: 6 months | — |
Countries
India
Contacts
Public ContactKiran Majjigeri
KLE University College of Pharmacy Belagavi
Outcome results
None listed